Failure to Respond to an ANDA Complete Response Letter Within the Regulatory Timeframe; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Failure to Respond to an ANDA Complete Response Letter Within the Regulatory Timeframe; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1464d ago.

Commenters (1)

• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%